Table 4. Plasma levels of CRP (mg/L) and fibrinogen (g/L) in patients undergoing PTA and stent implantation.
| Median (interquartile range) | p† | |||||
|---|---|---|---|---|---|---|
| PTA | p* | Stent | p* | Total EVT | ||
| CRP 0 | 3.6 (2-5.9) |
<0.001 | 4.6 (2.13-7.65) |
<0.001 | 3.7 (2.05-6) |
0.33 |
| CRP 8 h | 3.3 (1.65-5.75) |
4.6 (2.1-12) |
3.7 (1.9-6.75) |
0.09 | ||
| CRP 24 h | 6.2 (3.4-9.85) |
10.1 (3.08-14.73) |
6.2 (3.4-11.45) |
0.18 | ||
| CRP 48 h | 7 (3.65-14.05) |
12.75 (8.05-23.88) |
9.1 (4.3-17.7) |
0.03 | ||
| Fibrinogen 0 | 3.8 (3.4-4.5) |
0.001 | 3.8 (3.28-4.93) |
<0.001 | 3.8 (3.3-4.7) |
0.91 |
| Fibrinogen 8 h | 3.55 (3.2-4.03) |
3.7 (3-4.35) |
3.6 (3.13-4.1) |
0.94 | ||
| Fibrinogen 24 h | 4.05 (3.43-4.68) |
4 (3.35-5.15) |
4 (3.45-4.85) |
0.77 | ||
| Fibrinogen 48 h | 4.3 (3.6-5) |
4.9 (3.7-5.4) |
4.3 (3.7-5.2) |
0.15 | ||
*Friedman’s test; †Mann Whitney U test; CRP = C-reactive protein; EVT = endovascular treatment; PTA = percutaneous transluminal angioplasty